Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen

Andreas Peyrl, Monika Chocholous, Magnus Sabel, Álvaro Lassaletta, Jaroslav Štěrba, Pierre Leblond, Karsten Nysom, Ingrid Kristin Torsvik, Thomas Perwein, Neil D. Jones,

JAMA Oncology · 2023 · 37 citations · 30 references

DOIFull text

Open access

Abstract

ClinicalTrials.gov Identifier: NCT01356290.

References

30